Welcome to the fall edition of the U-M cancer e-newsletter. I'm pleased to be able once again to share some of the ways that U-M researchers at the University of Michigan Comprehensive Cancer Center are making great strides in understanding, diagnosing, preventing and treating cancer.
We're very excited to announce that a $13.6 million award from the National Cancer Institute will allow a national team of researchers centered at the U-M to examine how patients and doctors make breast cancer treatment decisions and how to improve the process for better outcomes.
In this issue you'll also read about how, along with our partners in Brazil, we've found two gene mutations driving adrenal cancer. You'll find a story about U-M research that shows psychological and social supports for adolescent cancer patients may be going unmet, and another about how prostate cancer survival rates have improved since the introduction of PSA testing. You can also read about the free iPhone and iPad app that we've developed to help patients monitor themselves for potential skin cancers.
Additionally, with the holidays so near at hand, we've included a story about 'alternative giving' and how some families and individuals have embraced the spirit of the season to benefit cancer patients, present and future. We profile one family with an annual giving tradition who this year have made U-M's Multidisciplinary Adrenal Cancer Program its charity of choice. And we also share the stories of people who have given in other ways, such as volunteering their time or making fleece lap blankets for patients undergoing chemotherapy.
Please remember, none of the advancements you'll read about in this issue would be possible without the support of people like you. On behalf of the entire cancer community at U-M, thank you for your continued interest in our work and your support of our mission.
Together, we are conquering cancer.
Max S. Wicha, M.D.
Director, University of Michigan Comprehensive Cancer Center
P. S., We'd like your feedback on this newsletter. Please send questions or comments to firstname.lastname@example.org.